Regulatory frameworks are a major force behind the growth of the biosimilar bevacizumab market. As authorities establish clearer pathways for reviewing biosimilar medicines, manufacturers can bring more competitive oncology products to market. This is particularly important as healthcare systems manage rising cancer treatment costs and increasing demand for biologic therapies. The global market...